Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Medicenna Therapeutics
(OTCQB:MDNAF)
Intraday
$1.81
-0.19
[-9.50%]
Get Report
Watch
Perks
Buy
Compare Brokers
$1.81
-0.19
[-9.50%]
At close: May 10
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Medicenna Therapeutics Stock (OTC:MDNAF)
Medicenna Therapeutics Stock (OTC: MDNAF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 09, 2023
Medicenna To Present 4 Year Follow-Up Phase 2b Bizaxofusp Survival Data In Recurrent Glioblastoma At The Society For Neuro-Oncology 2023 Annual Meeting
Benzinga Newsdesk
-
Nov 9, 2023, 9:15AM
Friday, May 29, 2020
Medicenna Updates Efficacy Results From Phase 2b Recurrent GBM Trial At ASCO 2020
Benzinga Newsdesk
-
May 29, 2020, 8:08AM
Wednesday, May 20, 2020
MDNA.TO: Data on MDNA55 and MDNA11 to be Presented at ASCO 2020…
Zacks Small Cap Research
-
May 20, 2020, 10:50AM
Thursday, April 16, 2020
The Spread of COVID-19 Has Caused Massive Volume Spikes In Securities On OTC Markets
Spencer Israel
-
Apr 16, 2020, 12:31PM
Monday, March 30, 2020
MDNA.TO: Encouraging MDNA19 Data in Non-Human Primates; Financing Funds Company Through End of 2022…
Zacks Small Cap Research
-
Mar 30, 2020, 11:25AM
Tuesday, March 24, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
-
Mar 24, 2020, 11:35AM
Tuesday, February 25, 2020
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
-
Feb 25, 2020, 10:15AM
Friday, February 21, 2020
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
-
Feb 21, 2020, 10:26AM
Thursday, February 20, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
-
Feb 20, 2020, 10:26AM
Wednesday, February 19, 2020
MDNA.TO: Cash Sufficient Through the End of 2020…
Zacks Small Cap Research
-
Feb 19, 2020, 9:25AM
Tuesday, January 14, 2020
MDNA.TO: End-of-Phase 2 Meeting with FDA for MDNA55 in 1Q20…
Zacks Small Cap Research
-
Jan 14, 2020, 2:20PM
Friday, December 27, 2019
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
-
Dec 27, 2019, 11:27AM
Friday, December 20, 2019
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
-
Dec 20, 2019, 11:59AM
Monday, December 02, 2019
MDNA.TO: Updated MDNA55 P2b Data Continues to Exceed Currently Available rGBM Therapies…
Zacks Small Cap Research
-
Dec 2, 2019, 10:40AM
Monday, November 25, 2019
Medicenna Highlights Efficacy In Phase 2b MDNA55 Trial At Society For Neuro-Oncology Annual Meeting
Benzinga Newsdesk
-
Nov 25, 2019, 7:31AM
Thursday, November 21, 2019
Medicenna Therapeutics Highlights Results On Drug Distribution From Recently-Completed Phase 2b Trial Of MDNA55 For Treatment Of Recurrent Glioblastoma
Benzinga Newsdesk
-
Nov 21, 2019, 8:19AM
Thursday, September 12, 2019
Medicenna Reports Will Present Latest Data From MDNA55 Trial In Recurrent Glioblastoma At Targeting Innate Immunity Congress Sep. 25, 2019
Benzinga Newsdesk
-
Sep 12, 2019, 7:09AM
Wednesday, July 31, 2019
Medicenna Selects its Lead Immuno-Oncology Clinical Candidate, MDNA19, from its IL-2 Superkine Platform
Benzinga Newsdesk
-
Jul 31, 2019, 7:56AM
Monday, June 03, 2019
Medicenna Earlier Reported Presentation Of Clinical Validation Of IL4 Receptor As Biomarker For MDNA55 In Recurrent Glioblastoma
Benzinga Newsdesk
-
Jun 3, 2019, 10:01AM
Thursday, May 16, 2019
Mediceena Highlights Presentation At ASCO
Benzinga Newsdesk
-
May 16, 2019, 7:24AM
